- |||||||||| sevoflurane / Generic mfg.
Trial completion, Surgery: HIPELD: Hip Fracture Surgery in Elderly Patients (clinicaltrials.gov) - Feb 6, 2015 P2, N=256, Completed, Initiation date: Jul 2005 --> Feb 2005 | Trial primary completion date: Nov 2013 --> Sep 2012 Recruiting --> Completed
- |||||||||| Enrollment closed, Trial primary completion date, Surgery: HipMo: Mortality Following Surgery for Proximal Femoral Fractures (clinicaltrials.gov) - Jan 28, 2015
P=N/A, N=500, Active, not recruiting, Trial primary completion date: Dec 2013 --> Dec 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Jun 2015
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Validation of Nexfin Cardiac Output in Elderly Patients With Hip Fracture (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=6, Terminated, Not yet recruiting --> Recruiting N=24 --> 6 | Recruiting --> Terminated | Trial primary completion date: Jun 2013 --> Oct 2013; Unable to recruit sufficient participants
- |||||||||| sevoflurane / Generic mfg.
Trial primary completion date, Surgery: HIPELD: Hip Fracture Surgery in Elderly Patients (clinicaltrials.gov) - Sep 16, 2014 P2, N=256, Recruiting, Recruiting --> Completed Trial primary completion date: May 2014 --> Dec 2014
- |||||||||| Trial termination, Trial primary completion date: A Multi-centre Study to Assess the Long-term Performance of the Summit (clinicaltrials.gov) - Sep 9, 2014
P4, N=293, Terminated, Trial primary completion date: May 2014 --> Dec 2014 Active, not recruiting --> Terminated | Trial primary completion date: Dec 2018 --> Nov 2011; Study closed after the 5 year end-point was reached after a review of the status further to a request from the investigators to discontinue participation.
- |||||||||| Trial initiation date: A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA (clinicaltrials.gov) - Sep 9, 2014
P4, N=184, Terminated, Active, not recruiting --> Terminated | Trial primary completion date: Dec 2018 --> Nov 2011; Study closed after the 5 year end-point was reached after a review of the status further to a request from the investigators to discontinue participation. Initiation date: Mar 2005 --> Jul 2005
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Multi-Centre Study to Assess the Long-term Performance of the DePuy ASR (clinicaltrials.gov) - Sep 9, 2014
P4, N=317, Terminated, N=624 --> 317 | Active, not recruiting --> Terminated | Trial primary completion date: Jun 2015 --> Nov 2011; DePuy discontinued this product in 4Q2009. At the time of this decision DePuy reviewed all clinical studies for this product and decided to close this Study
- |||||||||| tranexamic acid oral / Generic mfg.
Enrollment open, Trial initiation date, Trial primary completion date: The Effect of Tranexamic Acid on Transfusion Rates in Intertrochanteric Hip Fractures (clinicaltrials.gov) - Aug 21, 2014 P4, N=150, Recruiting, Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting | Initiation date: Jan 2014 --> Aug 2014 | Trial primary completion date: Jan 2016 --> Aug 2016
- |||||||||| Trial completion: Training of Patients With Hip Fracture (clinicaltrials.gov) - Aug 7, 2014
P2, N=100, Completed, N=120 --> 73 | Recruiting --> Terminated | Trial primary completion date: Jun 2015 --> Jun 2014; Recruiting slower than expected. Recruiting --> Completed
|